Inhibrx Biosciences develops cancer treatments built from engineered proteins, now in clinical trials. It last closed at $68.97 on Nov 20, down 7.21% on the day. The next earnings report for INBX is expected around Thu, Mar 18, 2027, after the close. For the quarter ended Sep 2026, INBX reported EPS of -$2.46 on revenue of $2.0M. Over its last 8 reports the stock moved an average of 5.9% the session after earnings. Over the last 12 months INBX insiders bought $6.3M of stock on the open market and sold $279K, according to SEC Form 4 filings.
AI Auto Pilots
Is INBX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold INBX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on INBXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
INBX · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 17% below its 20 day and 32% below its 50 day average. It is 34% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 37), near oversold. The nearest support is the Pivot S1 at $66.97, and the nearest resistance the Pivot at $70.78.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 10.2%/day
Key levels
$155.2952 week high+125.2%
$94.86100 day average+37.5%
$93.48Swing high (Nov 11)+35.5%
$92.47200 day average+34.1%
$91.1750 day average+32.2%
$80.8020 day average+17.2%
$72.79Pivot R1+5.5%
$70.78Pivot+2.6%
$68.97Last close
$66.97Pivot S1−2.9%
$66.80Swing low (Oct 30)−3.1%
$57.3052 week low−16.9%
Indicators
RSI (14)
37.01
Weak, oversold below 30
Neutral
MACD
-4.94
Below its signal line
Bearish
Stochastic
11.8
Near the bottom of its range
Oversold
ADX (14)
17.2
No clear trend
Williams %R
-97.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-104.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−18.4%
Change over 10 sessions
Bearish
ATR (14)
$7.07
Typical daily range, 10.3% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityHigh, 23.8%/day
Key levels
$155.2952 week high+125.2%
$94.86100 day average+37.5%
$93.48Swing high (Nov 11)+35.5%
$92.47200 day average+34.1%
$91.1750 day average+32.2%
$80.8020 day average+17.2%
$72.79Pivot R1+5.5%
$70.78Pivot+2.6%
$68.97Last close
$66.97Pivot S1−2.9%
$66.80Swing low (Oct 30)−3.1%
$57.3052 week low−16.9%
Indicators
RSI (14)
39.33
Weak, oversold below 30
Neutral
MACD
-2.75
Below its signal line
Bearish
Stochastic
18.9
Near the bottom of its range
Oversold
ADX (14)
23.1
Weak trend
Williams %R
-96.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-134.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−36.9%
Change over 10 sessions
Bearish
ATR (14)
$16.40
Typical daily range, 23.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200–
What happened before, for INBX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how INBX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for INBXHow many large options trades hit INBX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in INBX in the last 90 days.
From SEC Form 4 filings by INBX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether INBX is in one of them and how their past INBX trades turned out.
Inhibrx Biosciences is a biopharmaceutical company based in La Jolla, California. It develops biologic drug candidates, which are medicines made from proteins, using its own protein engineering platforms. Its candidates are being tested in clinical trials for cancers, including sarcomas, colorectal cancer, lung cancer and head and neck cancer. The company aims to offer these treatments to patients with serious diseases, if they are approved.